Notably, BIR disrupts dopamine (DA) neurotransmission (Kleinridders et al., 2015), a key regulator of motivation, reward, and mood (Zhou et al., 2024), linking metabolic dysfunction to both cognitive decline and NPS in AD. This evidence concerns the gene KCNJ11 and Alzheimer disease.